- Recent Funding
- Investors
- Fidelity
Fidelity portfolio
Fidelity has 40 portfolio companies on record at Recent Funding, with 6 investments in the last 12 months.
About this page
It is an institutional investor based in Boston, US, founded in 1946. It led 7 of the 37 rounds it joined. Its most recent investment on record is Harbinger's $240M Series B+ round in November 2026, alongside Panacea VC, Leitmotif, Xantium and 6 others. By category, its portfolio leans toward Health and bio (19) and Robotics and hardware (11). It has co-invested with T. Rowe Price, Baillie Gifford and RA Capital Management, most often T. Rowe Price (6 rounds).
About Fidelity
What Fidelity invests in
- Health and bio · 19 · 48%
- Robotics and hardware · 11 · 28%
- AI infrastructure and compute · 7 · 18%
- Manufacturing and industrial · 6 · 15%
- Developer tools and cloud · 5 · 13%
- Logistics and mobility · 3 · 8%
- AI agents · 3 · 8%
- Sales and marketing · 3 · 8%
Fidelity recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $240M | Panacea VC, Leitmotif, Xantium +6 | ||
| Series B+ · $90M | Janus Henderson Investors (lead), Duquesne Family Office, Octagon Capital Advisors (lead) +5 | ||
| Series B+ · $380M · lead | Walden Catalyst, Fidelity Management & Research Company, ING +6 | ||
| Series B+ · $107M | Fonds de solidarité FTQ, La Caisse, NAventures +5 | ||
| Series B+ · $99.5M | Viking Global Investors (lead), Casdin Capital, Slate Path Capital +6 | ||
| Series B+ · $220M | Venrock Healthcare Capital Partners (lead), Forbion Capital Partners, BrightEdge - American Cancer Society +5 | ||
| Series B+ · $360M | Venrock Healthcare Capital Partners (lead), HTGF, Fund+ +6 | ||
| Series A · $200M | Casdin Capital, AI Life Sciences Investments LLC (lead), ARCH Venture Partners +7 |
How Fidelity invests
Fidelity portfolio companies
HHarbinger$240MSeries B+ · Nov 2026
EEpicrispr Biotechnologies$90MSeries B+ · Aug 2026
NNearfield Instruments$380MSeries B+ · Jun 2026NNesto$107MSeries B+ · Jun 2026
CCity Therapeutics$99.5MSeries B+ · Jun 2026
CCellCentric$220MSeries B+ · May 2026
TTubulis$360MSeries B+ · Oct 2025TTreeline Biosciences$200MSeries A · Sep 2025
NNuro$106MSeries B+ · Apr 2025
RRetym$75MSeries B+ · Apr 2025
AAstranis$200MSeries B+ · Jul 2024
CCardurion Pharmaceuticals$260MSeries B+ · Jul 2024
EElement Biosciences$277MSeries B+ · Jul 2024
BBright Peak Therapeutics$90MSeries B+ · Jun 2024
FFrore SystemsSeries B+ · May 2024
SSiMa AI$70MSeries B+ · Apr 2024
MMMI$110MSeries B+ · Feb 2024
EEmalex Biosciences$250MSeries B+ · Nov 2022
TT-Knife$110MSeries B+ · Aug 2021
GGupshup$240MSeries B+ · Jul 2021
RRedwood Materials$700MSeries B+ · Jul 2021
ZZipline$250MSeries B+ · Jun 2021
AASAPP$120MSeries B+ · May 2021
EEthic$29MSeries B+ · Mar 2021
XXsight LabsSeries B+ · Mar 2021
FFever$12MSeries B+ · Nov 2015
TTenstorrentbacker
SSkyfall AIbacker
SSpaceXAIbacker
AAdvanCellbacker
OOurabacker
MMirador Therapeuticsbacker
SSkyrysebacker
RRapydbacker
CCanvabacker
AApplyboardbacker
SSoufflé Therapeuticsbacker
LLegorabacker
VVAST Databacker
AAnkyra Therapeuticsbacker
| Company | Round with Fidelity | Total raised | Latest raise |
|---|---|---|---|
Robotics and hardware |
Series B+ · $240M | $560M | Nov 5, 2026 Series B+ |
Health and bio |
Series B+ · $90M | $158M | Aug 11, 2026 Series B+ |
Robotics and hardware |
Series B+ · $380M · lead | $603.2M | Jun 22, 2026 Series B+ |
Lending and credit |
Series B+ · $107M | $237M | Jun 10, 2026 Series B+ |
Health and bio |
Series B+ · $99.5M | $234.5M | Aug 8, 2026 Series B+ |
Health and bio |
Series B+ · $220M | $340M | May 6, 2026 Series B+ |
Health and bio |
Series B+ · $360M | $573M | Oct 16, 2025 Series B+ |
Health and bio |
Series A · $200M | $461M | Sep 3, 2025 Series A |
Robotics and hardware |
Series B+ · $106M | $2.35B | Aug 21, 2025 Series B+ |
AI infrastructure and compute |
Series B+ · $75M | $75M | Nov 17, 2025 Series B+ |
Robotics and hardware |
Series B+ · $200M | $853.5M | May 6, 2026 Series B+ |
Health and bio |
Series B+ · $260M | $260M | Jul 16, 2024 Series B+ |
Health and bio |
Series B+ · $277M | $823M | Jun 9, 2026 Series B+ |
Health and bio |
Series B+ · $90M | $125M | Aug 17, 2026 Series B+ |
AI infrastructure and compute |
Series B+ · lead | $243M | Mar 17, 2026 Series B+ |
AI infrastructure and compute |
Series B+ · $70M | $495M | Sep 28, 2026 Series B+ |
Health and bio |
Series B+ · $110M · lead | $310M | Oct 8, 2026 Series B+ |
Health and bio |
Series B+ · $250M | $285M | Nov 3, 2022 Series B+ |
Health and bio |
Series B+ · $110M · lead | $188M | Aug 2, 2021 Series B+ |
AI agents |
Series B+ · $240M | $400M | Jul 23, 2025 round |
AI infrastructure and compute |
Series B+ · $700M | $3.02B | Jul 31, 2026 round |
Health and bio |
Series B+ · $250M | $1.57B | Mar 23, 2026 Series B+ |
AI agents |
Series B+ · $120M · lead | $310M | Jan 7, 2025 Series B+ |
Fintech |
Series B+ · $29M | $156M | Apr 3, 2025 Series B+ |
AI infrastructure and compute |
Series B+ | $300M | Jul 30, 2026 Series B+ |
In-person and live experiences |
Series B+ · $12M | $432M | Sep 1, 2025 Seed |
AI infrastructure and compute |
backer | $893M | Jan 7, 2026 Series B+ |
Foundation models and research |
backer | undisclosed | — |
| backer | undisclosed | Jan 6, 2026 Series B+ | |
Health and bio |
backer | $439.5M | Jul 15, 2026 Series B+ |
Health and bio |
backer | $1.24B | Jul 15, 2026 Series B+ |
Health and bio |
backer | $650M | Jan 13, 2026 Series B+ |
Legal and compliance |
backer | $513M | Feb 3, 2026 Series B+ |
Stablecoins |
backer | $760M | Aug 3, 2021 Series B+ |
Consumer and social |
backer | undisclosed | — |
HR and recruiting |
backer | undisclosed | — |
Health and bio |
backer | $335M | Oct 13, 2026 Series B+ |
Legal and compliance |
backer | $855.5M | May 1, 2026 Series B+ |
AI infrastructure and compute |
backer | $1.34B | Apr 22, 2026 Series B+ |
Health and bio |
backer | undisclosed | Oct 2, 2024 Series B+ |
Most frequent co-investors
TT. Rowe Price6 shared rounds · last Sep 3, 2025
BBaillie Gifford6 shared rounds · last Jul 24, 2024
RRA Capital Management5 shared rounds · last May 6, 2026
VVenrock5 shared rounds · last Jul 11, 2024
TTiger Global Management4 shared rounds · last Nov 5, 2026
IInvus4 shared rounds · last Jun 8, 2026
VValor Equity Partners4 shared rounds · last Nov 3, 2022
JJanus Henderson Investors3 shared rounds · last Aug 11, 2026
QQatar Investment Authority3 shared rounds · last Jun 22, 2026
CCasdin Capital3 shared rounds · last Jun 8, 2026
AARCH Venture Partners3 shared rounds · last Jun 8, 2026
RRock Springs Capital3 shared rounds · last Jun 8, 2026
Similar investors
SSignalFire39 companies · 10 deals in 12 mo
WWellington Management43 companies · 9 deals in 12 mo
BB Capital47 companies · 13 deals in 12 mo
SSofinnova Partners34 companies · 11 deals in 12 mo
CCanaan Partners34 companies · 1 deal in 12 mo
OOctopus Ventures33 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 37 rounds on Recent Funding that name Fidelity. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Fidelity, which is a subset of its real portfolio. API: /api/v1/investors/fidelity (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy